Cresco Labs (CRLBF) Capital Expenditures Growth (1y) (2021 - 2026)
Cresco Labs (CRLBF) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -21.54% |
| 10 | Cresco Labs | 240.39 Mn | 176.82 Mn | 75.45 Mn | -31.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.28% |
| Dec 31, 2025 | 265.12% |
| Sep 30, 2025 | -18.25% |
| Jun 30, 2025 | -18.81% |
| Mar 31, 2025 | -800.96% |
| Dec 31, 2024 | -84.16% |
| Sep 30, 2024 | 51.24% |
| Jun 30, 2024 | 72.23% |
| Mar 31, 2024 | -49.85% |
| Dec 31, 2023 | -30.71% |
| Sep 30, 2023 | 39.60% |
| Jun 30, 2023 | -190.48% |
| Mar 31, 2023 | 104.65% |
| Dec 31, 2022 | -10.27% |
| Sep 30, 2022 | 20.25% |
| Jun 30, 2022 | 53.24% |
| Mar 31, 2022 | -66.22% |
| Dec 31, 2021 | 7.74% |
| Mar 31, 2021 | 50.74% |